Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Terameprocol

Generic Name: Terameprocol

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₃₀O_₄

CAS Number: 24150-24-1

Unique Ingredient Identifier: 53YET703F2

Overview

Terameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.

Background

Terameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Terameprocol in Treating Patients With Recurrent High Grade Glioma

Phase 1

Completed

Posted: 2015/10/15

Sponsor:Sidney Kimmel Compre...

ID:NCT02575794

A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors

Phase 1

Terminated

Posted: 2008/04/23

Sponsor:

Erimos Pharmaceutica...

ID:NCT00664586

Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Phase 1

Terminated

Posted: 2008/04/23

Sponsor:

Erimos Pharmaceutica...

ID:NCT00664677

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Phase 1

Completed

Posted: 2006/11/28

Sponsor:Sidney Kimmel Compre...

ID:NCT00404248

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors

Phase 1

Completed

Posted: 2005/12/01

Sponsor:

Erimos Pharmaceutica...

ID:NCT00259818

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy